Desmopressin as a pharmacological tool in vasopressinergic hypothalamus-pituitary- adrenal axis modulation: Neuroendocrine, cardiovascular and coagulatory effects

Journal of Psychopharmacology

Volumn 25, Issue 3, 2011, Pages 353-360

  Jacobs, G E ^a   Hulskotte, Egj ^b   Van Gerven, Jma ^a   Zuurman, L ^a   De Kam, M L ^a   Elassaiss Schaap, J ^b   Ruigt, G ^b   Van Pelt, J ^c   Peeters, Bwmm ^b   Peeters, Pam ^b   Burggraaf, J ^a  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b NV ORGANON   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

challenge; desmopressin; function test; hypothalamus pituitary adrenal axis; stress related psychopathology; vasopressin

Indexed keywords

AMYLASE; ARGIPRESSIN; CORTICOTROPIN; DESMOPRESSIN; PLACEBO; PROLACTIN; VASOPRESSIN RECEPTOR; VON WILLEBRAND FACTOR;

ADULT; ANTIDIURESIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD CLOTTING; BOLUS INJECTION; CARDIOVASCULAR EFFECT; CORTICOTROPIN BLOOD LEVEL; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED HEADACHE; ENDOCRINE FUNCTION TEST; FACE DISORDER; FACIAL FLUSHING; FATIGUE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MAXIMUM PLASMA CONCENTRATION; NEUROMODULATION; NORMAL HUMAN; OSMOLALITY; PHARMACODYNAMICS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; ANTIDIURETIC AGENTS; AUTONOMIC NERVOUS SYSTEM; BLOOD COAGULATION; CROSS-OVER STUDIES; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; PITUITARY-ADRENAL SYSTEM; YOUNG ADULT;

EID: 79952133213     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109358203     Document Type: Article

References (31)

1. Agerso H., Seiding LL, Riis A., Lovgren U., Karlsson MO, Senderovitz T. (2004) Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients. Br J Clin Pharmacol 58: 352-358. (Pubitemid 39312458)
2. Aguilera G., Rabadan-Diehl C. (2000) Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 96: 23-29.
3. Aldasoro M., Medina P., Vila JM, Otero E., Martinez-Leon JB, Lluch S. (1997) Endothelium-dependent relaxation of human saphenous veins in response to vasopressin and desmopressin. J Vasc Surg 25: 696-703. (Pubitemid 27190934)
4. Burggraaf J., Schoemaker HC, Kroon JM, Huisman L., Kluft C., Cohen AF (1994) Influence of 1-desamino-8-D-vasopressin on endogenous fibrinolysis, haemodynamics and liver blood flow in healthy subjects. Clin Sci (Lond) 86: 497-503. (Pubitemid 24181936)
5. Callreus T., Odeberg J., Lundin S., Hoglund P. (1999) Indirect-response modeling of desmopressin at different levels of hydration. J Pharmacokinet Biopharm 27: 513-529.
6. Craighead M., Milne R., Campbell-Wan L., et al. (2008) Characterization of a novel and selective V1B receptor antagonist. Prog Brain Res 170: 527-535. (Pubitemid 352010248)
7. Dinan TG, Lavelle E., Scott LV, Newell-Price J., Medbak S., Grossman AB (1999) Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity. J Clin Endocrinol Metab 84: 2238-2240. (Pubitemid 30647061)
8. Dinan TG, O'Brien S., Lavelle E., Scott LV (2004) Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression. Psychol Med 34: 169-172. (Pubitemid 38139452)
9. Dinan TG, Scott LV (2005) Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin. J Anat 207: 259-264. (Pubitemid 41308808)
10. Evans DL, Charney DS, Lewis L., et al. (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58: 175-189. (Pubitemid 41112265)
11. Favrod-Coune C., Raux-Demay MC, Proeschel MF, Bertagna X., Girard F., Luton JP (1993) Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin. Clin Endocrinol (Oxf) 38: 405-410. (Pubitemid 23105074)
12. Fjellestad-Paulsen A., d'Agay-Abensour L., Hoglund P., Rambaud JC (1996) Bioavailability of 1-deamino-8-D-arginine vasopressin with an enzyme inhibitor (aprotinin) from the small intestine in healthy volunteers. Eur J Clin Pharmacol 50: 491-495. (Pubitemid 26281069)
13. Follenius M., Brandenberger G., Hietter B., Simeoni M., Reinhardt B. (1982) Diurnal cortisol peaks and their relationships to meals. J Clin Endocrinol Metab 55: 757-761. (Pubitemid 13232120)
14. Gijsman HJ, van Gerven JM, Tieleman MC, et al. (1998) Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. J Clin Psychopharmacol 18: 289-295. (Pubitemid 28353871)
15. Holsboer F. (1983) The dexamethasone suppression test in depressed patients: clinical and biochemical aspects. J Steroid Biochem 19: 251-257. (Pubitemid 13049818)
16. Holsboer F. (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501.
17. Lethagen S. (1994) Desmopressin (DDAVP) and hemostasis. Ann Hematol 69: 173-180. (Pubitemid 24314385)
18. Medina P., Segarra G., Vila JM, Chuan P., Domenech C., Lluch S. (1999) V2-receptor-mediated relaxation of human renal arteries in response to desmopressin. Am J Hypertens 12: 188-193. (Pubitemid 29130421)
19. Musselman DL, Betan E., Larsen H., Phillips LS (2003) Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54: 317-329. (Pubitemid 37267861)
20. Odeberg JM, Callreus T., Lundin S., Roth EB, Hoglund P. (2004) A pharmacokinetic and pharmacodynamic study of desmopressin: evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model. J Pharm Pharmacol 56: 1389-1398. (Pubitemid 39472067)
21. Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31: 464-468.
22. Ramasubbu R. (2002) Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypotheses 59: 537-551. (Pubitemid 35216791)
23. Rembratt A., Graugaard-Jensen C., Senderovitz T., Norgaard JP, Djurhuus JC (2004) Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years. Eur J Clin Pharmacol 60: 397-402. (Pubitemid 39214892)
24. Ring RH (2005) The central vasopressinergic system: examining the opportunities for psychiatric drug development. Curr Pharm Des 11: 205-225. (Pubitemid 40089841)
25. Rohleder N., Nater UM, Wolf JM, Ehlert U., Kirschbaum C. (2004) Psychosocial stress-induced activation of salivary alpha-amylase: an indicator of sympathetic activity ? Ann N Y Acad Sci 1032: 258-263. (Pubitemid 40298488)
26. Scott LV, Dinan TG (1998) Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci 62: 1985-1998. (Pubitemid 28239711)
27. Scott LV, Dinan TG (2002) Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord 72: 113-124. (Pubitemid 35012021)
28. Scott LV, Medbak S., Dinan TG (1999 a) ACTH and cortisol release following intravenous desmopressin: a dose-response study. Clin Endocrinol (Oxf) 51: 653-658.
29. Scott LV, Medbak S., Dinan TG (1999 b) Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers. Biol Psychiatry 45: 1447-1454. (Pubitemid 29457557)
30. Smarius LJ, Jacobs GE, Hoeberechts-Lefrandt DH, et al. (2008) Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa. J Psychopharmacol 22: 426-433.
31. Spiga F., Harrison L., Macsweeney C., Thomson F., Craighead M., Lightman S (2009) Effect of vasopressin 1b receptor blockade on the hypothalamic- pituitary-adrenal response of chronically stressed rats to a heterotypic stressor. J Endocrinol 200 (3). 285-291.